Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Unum Group Q1 Earnings Miss Estimates on Higher Expenses

In This Article:

Unum Group’s UNM first-quarter 2025 operating net income of $2.04 per share missed the Zacks Consensus Estimate by 6.8%. The bottom line decreased 3.8% year over year.

The quarterly results reflected higher premiums and solid performances across Unum International, Colonial Life and Closed Block segments, partially offset by weakness in the Unum U.S and Corporate segments. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)

Unum Group’s Operational Update

Total operating revenues of Unum Group were $3.3 billion, up 3% year over year, driven by higher premium income and other income. However, the top line missed the Zacks Consensus Estimate by 1.1%.

Premiums increased 3.5% from the prior-year quarter to $2.7 billion and were in line with our estimate.

Unum Group Price, Consensus and EPS Surprise

Unum Group Price, Consensus and EPS Surprise
Unum Group Price, Consensus and EPS Surprise

Unum Group price-consensus-eps-surprise-chart | Unum Group Quote

Total benefits and expenses rose 5.3% year over year to $2.8 billion, largely attributable to higher policy benefits, including remeasurement gain, commissions, interest and debt expense and other expenses. The figure matched our estimate.

Quarterly Segment Update of Unum Group

Unum U.S.: Premium income was $1.8 billion, up 4.3% year over year. 

Adjusted operating income declined 14.6% year over year to $329.1 million. Our estimate was $325.3 million, while the Zacks Consensus Estimate was $344 million.

Unum International: Premium income of $246.7 million jumped 6.5% year over year. Adjusted operating income was $38.7 million, up 3.5% year over year. Our estimate was $42.9 million, while the Zacks Consensus Estimate was $42.6 million.

The Unum U.K. line of business premium income was £161.5 million, up 4.9% from the year-ago quarter, primarily due to in-force block growth. Adjusted operating income in local currency of £29.5 million was up 4.6% from a year ago.

The benefit ratio was 67.1, which improved 100 basis points (bps) due to lower incidence in the supplemental product line. Sales decreased 28% to £21.3 million.

Persistency increased in the group life product line and supplemental product line, but decreased in the group long-term disability product line.

Colonial Life: Premium income rose 2.3% from the prior-year figure to $457.3 million, primarily due to prior-period sales in all product lines. 

Sales increased 2.2% from the year-ago figure to $105.3 million. Adjusted operating income climbed 1.8% from the prior-year period to $115.7 million. Our estimate was $108 million, while the Zacks Consensus Estimate was $119 million.

Persistency was 78.1%, which decreased 30 bps year over year.

The benefit ratio improved 90 bps year over year to 47.7, primarily due to favorable benefit experience in the life and cancer and critical illness product lines.

Closed Block: Adjusted operating income was $24.4 million, which inched up 0.4% year over year. Our estimate was $32.6 million, while the Zacks Consensus Estimate was pegged at $36.6 million.

Corporate: The segment incurred an adjusted operating loss of $41.1 million, narrower than the loss of $46.1 million in the year-earlier quarter. The lower loss was due to an increase in net investment income, owing to a rise in the level of invested assets. Our estimate for loss was $50 million, while the Zacks Consensus Estimate was pegged at a loss of $49.91 million.